Realize new value through strategic partnerships

The pressure to accelerate time-to-market for innovative pharmaceutical products has never been more intense. Every biopharmaceutical company feels the need to drive promising therapies through development and gain market approval as quickly as possible to maximize the value of its assets. At the same time, current market and economic realities are compelling the industry to reduce fixed costs, increase efficiency, and concentrate limited resources on core competencies. The challenge of accelerating product development while controlling costs creates a difficult balancing act for industry executives.
 
Leveraging strategic partnerships allows bio/pharmaceutical companies to greatly increase operational efficiency by focusing their resources on the highest priorities – such as discovery research and product marketing – while utilizing the specialized expertise and infrastructure of their partners for other services.
 
To recognize the value of a strategic relationship, biopharmaceutical companies need an experienced and trusted outsourcing partner—a partner who can provide the deep expertise, flexibility, and efficiencies of a worldwide infrastructure. Few companies can respond to this market opportunity the way PAREXEL can.

Our capabilities are complete and integrated. Our global resources are key attributes of an effective partner who can deliver end-to-end solutions that fit precisely with our clients’ needs, regardless of the size or complexity of their undertakings. Our collective expertise, our global reach, and our broad experience can provide a strategic advantage for our clients.